tecentriq Archives - Journal for Clinical Studies

Current Edition

Regional News

Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?

Roche’s Tecentriq has ushered in a new era, offering the first immunotherapy option for non-small cell lung cancer (NSCLC) patients right after tumour surgery. But do...

20 October 2021 Regional News immunotherapy | lung cancer

Continue Reading →

Europe

Tecentriq extends streak with win in breast cancer trial

Roche's checkpoint inhibitor Tecentriq helped extend progression-free survival in a Phase 3 study of patients with a hard-to-treat form of metastatic breast cancer...

4 July 2018 Europe | news breast | cancer

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?

Tecentriq extends streak with win in breast cancer trial

Journal for Clinical Studies